Nobody has studied it. A systematic review screened 1,471 records looking for a comparison of injection days and found none [1]. Three studies met inclusion and not one of them compared a Tuesday against a Saturday. Pick the day you will remember.
The internet answers this confidently. Take it Friday so the worst days fall on the weekend. Or Monday, so you are not nauseated at a social event. The review went looking for the evidence behind that advice. It sits beside the other question people ask constantly and answer confidently, covered in slow responders at week eight.
What the search actually found
1,471 records narrowed to 1,000 after deduplication. Two stages of screening against predefined criteria left three studies. Those were the SUSTAIN 4 trial of once-weekly semaglutide and a retrospective case series on alternate-day oral dosing. The third was an expert panel discussion of flexible schedules. Not one compared different days of the week for an injectable.
What has been tested is frequency
How often, not which day. A phase 2b trial put a fortnightly injection against a weekly one [2]. HbA1c fell 2.28 points on bofanglutide 18 mg every two weeks against 1.60 on weekly semaglutide.
The cost showed up in the stomach. Gastrointestinal adverse events affected 81.8% to 87.3% of the fortnightly arms against 51.9% on semaglutide. So halving the injections raised the nausea, and bofanglutide is approved nowhere.
The variable that is worth optimizing
The dose, not the day. Among 20,998 tirzepatide buyers without type 2 diabetes, 74.2% were still under 10 mg by the sixth fill [3]. Escalation ran slower than in the trials.
Semaglutide looks the same. Twelve months in, 48% of one clinic’s 206 patients were still taking it [4]. 40% of those were at 1.0 mg a week or less. That is the rung most buyers actually sit on. It is the one a price list is least likely to headline.
A seller charging by dose and a seller charging flat are the same price at 2.5 mg. At 15 mg they are not. Which of the two you are buying is knowable before you order. Most people never reach the top rung. Six months at a realistic dose is the figure to compare.
What can be said about timing
These drugs are labeled for once-weekly administration. The practical goal is a day you will reliably remember. A missed or late dose is a real effect; a Tuesday-versus-Saturday difference is a hypothetical one.
If nausea reliably arrives the day after your injection, moving the injection is a reasonable experiment to run with a prescriber. Do not run it by skipping a week. A gap and a restart carry their own trouble, set out in restarting after a break.
One note on the review itself
An absence is only as trustworthy as the search behind it. Alongside PubMed and Google Scholar, the authors used an AI-assisted search tool, which is an unusual choice for a systematic review.
The direction is not really in doubt. A trial randomizing injection day would be memorable. Read the screening counts as approximate.
The broader point is that a lot of practical advice about these drugs has nothing behind it. That is worth remembering when onboarding material speaks with certainty about schedules or timing. Most people are gone within a year regardless of which day they picked.